Xiangyi Ren

1.1k total citations · 2 hit papers
13 papers, 882 citations indexed

About

Xiangyi Ren is a scholar working on Materials Chemistry, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Xiangyi Ren has authored 13 papers receiving a total of 882 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Materials Chemistry, 3 papers in Molecular Biology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Xiangyi Ren's work include Advanced Nanomaterials in Catalysis (4 papers), Cardiac Ischemia and Reperfusion (3 papers) and MicroRNA in disease regulation (2 papers). Xiangyi Ren is often cited by papers focused on Advanced Nanomaterials in Catalysis (4 papers), Cardiac Ischemia and Reperfusion (3 papers) and MicroRNA in disease regulation (2 papers). Xiangyi Ren collaborates with scholars based in China. Xiangyi Ren's co-authors include Minfeng Huo, Yabing Zhang, Dongxu Chen, Xi Li, Hongying Chen, Yan Wang, Huifang Li, Mengmeng Wang, Jun‐Jie Yin and Honghong Chen and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and ACS Nano.

In The Last Decade

Xiangyi Ren

12 papers receiving 867 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nanozymes-recent development and biomedical applications

2022 296 citations Xiangyi Ren, Dongxu Chen et al. Journal of Nanobiotechnology profile →
Dendritic Polymer‐Based Nanomedicines Remodel the Tumor Stroma: Improve Drug Penetration and Enhance Antitumor Immune Response

2024 75 citations Yuxin Zhang, Dayi Pan et al. Advanced Materials profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiangyi Ren China	8	482	399	287	138	103	13	882
Qunqun Bao China	11	469 1.0×	570 1.4×	302 1.1×	275 2.0×	57 0.6×	15	1.1k
Tiancong Ma China	14	456 0.9×	549 1.4×	355 1.2×	291 2.1×	46 0.4×	22	1.0k
Hui Hu China	13	530 1.1×	575 1.4×	502 1.7×	138 1.0×	64 0.6×	32	1.3k
Lihua Kang China	12	768 1.6×	763 1.9×	424 1.5×	139 1.0×	82 0.8×	13	1.3k
Yu‐Jen Lu Taiwan	18	273 0.6×	529 1.3×	352 1.2×	388 2.8×	140 1.4×	31	1.0k
Chuanyao Yang China	11	288 0.6×	415 1.0×	277 1.0×	330 2.4×	54 0.5×	18	873
Linji Gong China	15	543 1.1×	725 1.8×	242 0.8×	222 1.6×	62 0.6×	19	1.1k
Diana Askhatova Canada	8	483 1.0×	502 1.3×	246 0.9×	212 1.5×	76 0.7×	8	912
He Ding China	23	803 1.7×	878 2.2×	297 1.0×	181 1.3×	143 1.4×	46	1.3k

Countries citing papers authored by Xiangyi Ren

Since Specialization

Citations

This map shows the geographic impact of Xiangyi Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangyi Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangyi Ren more than expected).

Fields of papers citing papers by Xiangyi Ren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangyi Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangyi Ren. The network helps show where Xiangyi Ren may publish in the future.

Co-authorship network of co-authors of Xiangyi Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangyi Ren. A scholar is included among the top collaborators of Xiangyi Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangyi Ren. Xiangyi Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Zhang, Yabing, Di Zhao, Panmiao Liu, et al.. (2025). Magnesium hexacyanoferrate mitigates sepsis-associated encephalopathy through inhibiting microglial activation and neuronal cuproptosis. Biomaterials. 321. 123279–123279. 2 indexed citations

Ren, Xiangyi, et al.. (2025). Advancements in nanomedicine for modulating ischemic cardiomyopathy therapy. Materials Today Bio. 34. 102238–102238.

Li, Xi, Yu Yao, Xiangyi Ren, et al.. (2025). Strontium Hexacyanoferrate Nanomedicine Alleviates Ischemic Cardiomyopathy by Regulating Pyroptosis. Advanced Functional Materials. 35(35). 5 indexed citations

Chen, Dongxu, Lü Huang, Bowen Zhang, et al.. (2024). Magnesium hexacyanoferrate nanocatalysts alleviates fibromyalgia syndrome by reversing cellular ferroptosis. Chemical Engineering Journal. 498. 155019–155019. 3 indexed citations

Huang, Tengda, Hongying Chen, Tian Wu, et al.. (2024). Comprehensive analysis of bioinformatics and system biology reveals the association between Girdin and hepatocellular carcinoma. PLoS ONE. 19(12). e0315534–e0315534. 1 indexed citations

Zhang, Yuxin, Dayi Pan, Yunkun Li, et al.. (2024). Dendritic Polymer‐Based Nanomedicines Remodel the Tumor Stroma: Improve Drug Penetration and Enhance Antitumor Immune Response. Advanced Materials. 36(25). e2401304–e2401304. 75 indexed citations breakdown →

Li, Xi, Xiangyi Ren, Maodi Xie, et al.. (2023). Biominerallized Noble Metal‐Based RuO₂ Nanozymes Against Myocardial Ischemic/Reperfusion Injury. SHILAP Revista de lepidopterología. 3(5). 11 indexed citations

Li, Xi, Xiangyi Ren, Yabing Zhang, et al.. (2022). Fabry disease: Mechanism and therapeutics strategies. Frontiers in Pharmacology. 13. 1025740–1025740. 26 indexed citations

Ren, Xiangyi, Dongxu Chen, Yan Wang, et al.. (2022). Nanozymes-recent development and biomedical applications. Journal of Nanobiotechnology. 20(1). 92–92. 296 indexed citations breakdown →

10.

Zhang, Yabing, Xiangyi Ren, Yan Wang, et al.. (2021). Targeting Ferroptosis by Polydopamine Nanoparticles Protects Heart against Ischemia/Reperfusion Injury. ACS Applied Materials & Interfaces. 13(45). 53671–53682. 98 indexed citations

11.

Li, Xi, Yabing Zhang, Xiangyi Ren, et al.. (2021). Ischemic Microenvironment‐Responsive Therapeutics for Cardiovascular Diseases. Advanced Materials. 33(52). e2105348–e2105348. 47 indexed citations

12.

Ren, Xiangyi, Minfeng Huo, Mengmeng Wang, et al.. (2019). Highly Catalytic Niobium Carbide (MXene) Promotes Hematopoietic Recovery after Radiation by Free Radical Scavenging. ACS Nano. 13(6). 6438–6454. 218 indexed citations

13.

Hao, Yongwei, Bingxiang Zhang, Cuixia Zheng, et al.. (2015). The tumor-targeting core–shell structured DTX-loaded PLGA@Au nanoparticles for chemo-photothermal therapy and X-ray imaging. Journal of Controlled Release. 220(Pt A). 545–555. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact